Rapid Response COVID-19
Antigen Rapid Test Device is a rapid screening test
that detects the presence of
the COVID-19 antigen. This is an in vitro
immunochromatographic assay for
the direct and qualitative detection of viral
SARS-CoV-2 nucleoprotein antigens
from nasal and nasopharyngeal secretions of
individuals suspected of having
contracted COVID-19 within 6 days of symptom
onset. This test is authorized
for use at the point-of-care, i.e., in patient care setting.
It can also be administered in
the workplace to employees by health professionals
such as doctors, nurses and other
qualified professionals or administrative staff who
have received prior training.
Non-medical staff can only perform nasal tests.
One box of the Rapid Response
COVID-19 Antigen Rapid Test Device will allow
you to test 25 people. for $
498.75 ($ 19.95 / test)